← All trials
NCT05327816
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 13, 2022
- Primary completion
- Jun 18, 2029
- Completion date
- Jun 18, 2029
- First posted
- Apr 14, 2022
- Last posted
- Dec 21, 2022
- Enrollment
- 1600
- Arms / groups
- 19 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Janssen Pharmaceutica NVLead sponsor
- Janssen Pharmaceutica NVStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.